JP2005511504A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511504A5
JP2005511504A5 JP2003526440A JP2003526440A JP2005511504A5 JP 2005511504 A5 JP2005511504 A5 JP 2005511504A5 JP 2003526440 A JP2003526440 A JP 2003526440A JP 2003526440 A JP2003526440 A JP 2003526440A JP 2005511504 A5 JP2005511504 A5 JP 2005511504A5
Authority
JP
Japan
Prior art keywords
hemoglobin
stored
blood cells
red blood
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003526440A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511504A (ja
Filing date
Publication date
Priority claimed from US09/950,270 external-priority patent/US6811778B2/en
Application filed filed Critical
Publication of JP2005511504A publication Critical patent/JP2005511504A/ja
Publication of JP2005511504A5 publication Critical patent/JP2005511504A5/ja
Pending legal-status Critical Current

Links

JP2003526440A 2001-09-10 2002-09-10 貯蔵された赤血球による酸素輸送の改善方法 Pending JP2005511504A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/950,270 US6811778B2 (en) 2001-09-10 2001-09-10 Method for improving oxygen transport by stored red blood cells
PCT/US2002/028903 WO2003022312A1 (en) 2001-09-10 2002-09-10 Method for improving oxygen transport by stored red blood cells

Publications (2)

Publication Number Publication Date
JP2005511504A JP2005511504A (ja) 2005-04-28
JP2005511504A5 true JP2005511504A5 (https=) 2006-01-05

Family

ID=25490200

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003526440A Pending JP2005511504A (ja) 2001-09-10 2002-09-10 貯蔵された赤血球による酸素輸送の改善方法

Country Status (5)

Country Link
US (2) US6811778B2 (https=)
EP (1) EP1425047A4 (https=)
JP (1) JP2005511504A (https=)
CN (1) CN100534534C (https=)
WO (1) WO2003022312A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1863380B1 (en) 2005-03-01 2019-10-02 Masimo Laboratories, Inc. Multiple wavelength sensor attachment
US8265723B1 (en) 2006-10-12 2012-09-11 Cercacor Laboratories, Inc. Oximeter probe off indicator defining probe off space
WO2008063868A2 (en) * 2006-11-07 2008-05-29 The General Hospital Corporation Attenuation of vasoactive oxygen carrier-induced vasoconstriction
US8781544B2 (en) 2007-03-27 2014-07-15 Cercacor Laboratories, Inc. Multiple wavelength optical sensor
US8374665B2 (en) 2007-04-21 2013-02-12 Cercacor Laboratories, Inc. Tissue profile wellness monitor
US8871434B2 (en) * 2008-03-21 2014-10-28 Fenwal, Inc. Red blood cell storage medium for extended storage
US8968992B2 (en) * 2008-03-21 2015-03-03 Fenwal, Inc. Red blood cell storage medium for extended storage
US11864553B2 (en) 2009-10-23 2024-01-09 Fenwal, Inc. Methods and systems for providing red blood cell products with reduced plasma
US9839381B1 (en) 2009-11-24 2017-12-12 Cercacor Laboratories, Inc. Physiological measurement system with automatic wavelength adjustment
US8801613B2 (en) 2009-12-04 2014-08-12 Masimo Corporation Calibration for multi-stage physiological monitors
CN104159591A (zh) 2011-11-07 2014-11-19 通用医疗公司 红细胞的处理
EP2827887A4 (en) * 2012-03-20 2016-04-20 Einstein Coll Med METHOD FOR IMPROVING THE EFFECTIVENESS OF BLOOD TRANSFUSIONS
US11504417B2 (en) 2017-07-18 2022-11-22 VirTech Bio, Inc. Blood substitutes comprising hemoglobin and methods of making
US20210352887A1 (en) * 2018-10-12 2021-11-18 VirTech Bio, Inc. Oxygenation media for ex-vivo preservation of organs and tissues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3778006D1 (de) * 1986-11-10 1992-05-07 Biopure Corp Hochreines, halbsynthetisches blutsurrogat.
CA1312009C (en) 1986-11-10 1992-12-29 Carl W. Rausch Extra pure semi-synthetic blood substitute
US5344393A (en) * 1992-02-28 1994-09-06 Alliance Pharmaceutical Corp. Use of synthetic oxygen carriers to facilitate oxygen delivery
US5865784A (en) * 1995-06-07 1999-02-02 Alliance Pharmaceutical Corp. Method of hemodilution facilitated by monitoring oxygenation status

Similar Documents

Publication Publication Date Title
JP2005511504A5 (https=)
Crowther et al. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin
Pitt et al. Lignocaine given prophylactically to patients with acute myocardial infarction
JP2022031772A5 (https=)
Jung et al. A fatal case of intravascular coagulation after bee sting acupuncture
RU2002127804A (ru) Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения
JP2003515533A5 (https=)
EP0631784A1 (en) Sulphated polysaccharides having anti-inflammatory activity
JP2000514091A (ja) 心筋症の処置
JP2015515462A5 (https=)
JP2001510795A5 (https=)
EP4667008A3 (en) Methods and compositions for treating rna viral infections
MX2013005641A (es) Composiciones anti-inflamatorias.
Fäh Septic deep venous thrombosis in intravenous drug users
JPS6169722A (ja) 医薬用組成物
KR20170031084A (ko) 자가소화의 치료용의 조성물
CA2574450A1 (en) Method of treating hyperphosphataemia using lanthanum hydroxycarbonate
CA2247389A1 (en) Agent for treatment of bladder troubles
JP2006502231A5 (https=)
Ximenes et al. Dental infection associated with exuberant gingival necrosis in a patient with paroxysmal nocturnal hemoglobinuria: A case report
JPS60208917A (ja) Ａｒｄｓおよび多器官不全治療、予防におけるプロスタグランジンの使用
RU2340354C1 (ru) Кровезаменитель с функцией переноса кислорода
Kashyap et al. Management of hemophilia in developing countries
Ramavath et al. Successful surgical management of primary abdominal wall mucormycosis in an immunocompetent patient
NL2025829B1 (en) Use of phenol in treatment of systemic oxidative stress mediated diseases